UB Paderborn / Katalog / Suche / in CDI

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis

Movement disorders clinical practice (Hoboken, N.J.), 2019-11, Vol.6 (8), p.639-651

2019

Volltextzugriff (PDF)

The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17

International journal of molecular sciences, 2020-12, Vol.22 (1), p.118

2020

Volltextzugriff (PDF)

The Role of Bacterial-Derived Aromatic Amino Acids Metabolites Relevant in Autism Spectrum Disorders: A Comprehensive Review

Frontiers in neuroscience, 2021-10, Vol.15, p.738220-738220

2021

Volltextzugriff (PDF)

The Autism Spectrum Disorder-Associated Bacterial Metabolite p-Cresol Derails the Neuroimmune Response of Microglial Cells Partially via Reduction of ADAM17 and ADAM10

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11013

2022

Volltextzugriff (PDF)

Pharmacological validation of TDO as a target for Parkinson’s disease

The FEBS journal, 2021-07, Vol.288 (14), p.4311-4331

2021

Volltextzugriff (PDF)

The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids

Frontiers in endocrinology (Lausanne), 2019-04, Vol.10, p.247-247

2019

Volltextzugriff (PDF)

Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice

Gut, 2019-05, Vol.68 (5), p.829

2019

Volltextzugriff (PDF)

The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies

European journal of pharmacology, 2017-12, Vol.817, p.86-95

2017

Volltextzugriff (PDF)

A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate‐to‐severe asthma

Clinical and translational allergy, 2023-11, Vol.13 (11), p.e12306-n/a

2023

Volltextzugriff (PDF)

Genome, Environment, Microbiome and Metabolome in Autism (GEMMA) Study Design: Biomarkers Identification for Precision Treatment and Primary Prevention of Autism Spectrum Disorders by an Integrated Multi-Omics Systems Biology Approach

Brain sciences, 2020-10, Vol.10 (10), p.1

2020

Volltextzugriff (PDF)

The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders

International journal of molecular sciences, 2021-09, Vol.22 (18), p.10052

2021

Volltextzugriff (PDF)

Gut-brain and brain-gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet

Nutritional neuroscience, 2018-07, Vol.21 (6), p.391-402

2018

Volltextzugriff (PDF)

A robust microbiome signature for autism spectrum disorder across different studies using machine learning

Scientific reports, 2024-01, Vol.14 (1), p.814-814, Article 814

2024

Volltextzugriff (PDF)

Buty and the beast: the complex role of butyrate in Parkinson's disease

Frontiers in pharmacology, 2024-04, Vol.15, p.1388401-1388401

2024

Volltextzugriff (PDF)

Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence

Microorganisms (Basel), 2020-09, Vol.8 (9), p.1369

2020

Volltextzugriff (PDF)

Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease

Current behavioral neuroscience reports, 2017, Vol.4 (4), p.361-368

2017

Volltextzugriff (PDF)

Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease

Frontiers in aging neuroscience, 2018-08, Vol.10, p.237-237

2018

Volltextzugriff (PDF)

Aging in Male Wistar Rats Associates With Changes in Intestinal Microbiota, Gut Structure, and Cholecystokinin-Mediated Gut–Brain Axis Function

The journals of gerontology. Series A, Biological sciences and medical sciences, 2021-11, Vol.76 (11), p.1915-1921

2021

Volltextzugriff (PDF)

Exploring Braak's Hypothesis of Parkinson's Disease

Frontiers in neurology, 2017-02, Vol.8, p.37-37

2017

Volltextzugriff (PDF)

Nigrostriatal 6-hydroxydopamine lesions increase alpha-synuclein levels and permeability in rat colon

Neurobiology of aging, 2023-09, Vol.129, p.62-71

2023

Volltextzugriff (PDF)

Prebiotic diet normalizes aberrant immune and behavioral phenotypes in a mouse model of autism spectrum disorder

Acta pharmacologica Sinica, 2024-08, Vol.45 (8), p.1591-1603

2024

Volltextzugriff (PDF)

The interaction between intestinal bacterial metabolites and phosphatase and tensin homolog in autism spectrum disorder

Molecular and cellular neuroscience, 2023-03, Vol.124, p.103805-103805, Article 103805

2023

Volltextzugriff (PDF)

Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease

Frontiers in aging neuroscience, 2017-03, Vol.9, p.57-57

2017

Volltextzugriff (PDF)

Impairment of skeletal muscle insulin action with aging in Wistar rats: Role of leptin and caloric restriction

Mechanisms of ageing and development, 2012-05, Vol.133 (5), p.306-316

2012

Volltextzugriff (PDF)

247 The Role of Toll-Like Receptor-4 in Gut-Brain Cross Talk in a Murine Model of Parkinson's Disease

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-59-S-59

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis

The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17

The Role of Bacterial-Derived Aromatic Amino Acids Metabolites Relevant in Autism Spectrum Disorders: A Comprehensive Review

The Autism Spectrum Disorder-Associated Bacterial Metabolite p-Cresol Derails the Neuroimmune Response of Microglial Cells Partially via Reduction of ADAM17 and ADAM10

Pharmacological validation of TDO as a target for Parkinson’s disease

The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids

Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice

The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies

A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate‐to‐severe asthma

Genome, Environment, Microbiome and Metabolome in Autism (GEMMA) Study Design: Biomarkers Identification for Precision Treatment and Primary Prevention of Autism Spectrum Disorders by an Integrated Multi-Omics Systems Biology Approach

The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders

Gut-brain and brain-gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet

A robust microbiome signature for autism spectrum disorder across different studies using machine learning

Buty and the beast: the complex role of butyrate in Parkinson's disease

Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence

Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease

Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease

Aging in Male Wistar Rats Associates With Changes in Intestinal Microbiota, Gut Structure, and Cholecystokinin-Mediated Gut–Brain Axis Function

Exploring Braak's Hypothesis of Parkinson's Disease

Nigrostriatal 6-hydroxydopamine lesions increase alpha-synuclein levels and permeability in rat colon

Prebiotic diet normalizes aberrant immune and behavioral phenotypes in a mouse model of autism spectrum disorder

The interaction between intestinal bacterial metabolites and phosphatase and tensin homolog in autism spectrum disorder

Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease

Impairment of skeletal muscle insulin action with aging in Wistar rats: Role of leptin and caloric restriction

247 The Role of Toll-Like Receptor-4 in Gut-Brain Cross Talk in a Murine Model of Parkinson's Disease

Suchergebnisse filtern